HER2, HER3, and TROP2: Diagnostic Testing and Treatment Implications in Breast, GI, and Lung Cancers

Review the latest expert guidance on assessing and targeting HER2 HER3 and TROP2 in the metastatic setting for diverse malignancies with on-demand Webcasts and downloadable slides from CCO&rsquo s live Webinars along with expert-authored commentaries a pocket guide on best practices for testing and brief Medical Minute slide/audio presentations for oncologists and pathologists.

Share

Program Content

Activities

HER2/3/TROP2 in MBC
Diagnostic Testing for HER2, HER3, and TROP2 and Treatment Implications in Metastatic Breast Cancer
Congratulations: You achieved a completion on 04/09/2022
Targeting HER2/3/TROP2 in MBC
Targeting HER2, HER3 and TROP2 in Breast Cancer
Congratulations: You achieved a completion on 04/09/2022
HER2 in GI Cancers
Assessment of HER2 Status and Targeting HER2 in Gastrointestinal Cancers
Congratulations: You achieved a completion on 04/09/2022
Overview
An Overview of HER2, HER3, and TROP2 Testing and Targeted Treatment in Breast and GI Cancers
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 17, 2020

Expires: December 16, 2021

Activities

HER2 in MBC
Diagnostic Testing for HER2, HER3, and TROP2 and Treatment Implications in Metastatic Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 30, 2020

Expires: July 29, 2021

<i>EP</i>: HER2 in MBC
ExpressPoints: Diagnostic Testing for HER2, HER3, and TROP2 and Treatment Implications in Metastatic Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 30, 2020

Expires: July 29, 2021

Targeting HER2 in MBC
Targeting HER2, HER3, and TROP2 in Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 21, 2020

Expires: August 20, 2021

<i>EP</i>: Targeting HER2 in MBC
ExpressPoints: Targeting HER2, HER3, and TROP2 in Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 24, 2020

Expires: August 23, 2021

HER2 in GI Cancers
Assessment of HER2 Status and Targeting HER2 in Gastrointestinal Cancers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 25, 2020

Expires: September 24, 2021

<em>EP</em>: HER2 in GI Cancers
ExpressPoints: Assessment of HER2 Status and Targeting HER2 in Gastrointestinal Cancers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 30, 2020

Expires: September 29, 2021

Overview
An Overview of HER2, HER3, and TROP2 Testing and Targeted Treatment in Breast and GI Cancers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 29, 2020

Expires: October 28, 2021

<i>EP</i>: Overview
ExpressPoints: An Overview of HER2, HER3, and TROP2 Testing and Targeted Treatment in Breast and GI Cancers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 30, 2020

Expires: October 29, 2021

Activities

Summary Reference
Clinical Pocket Guide: Diagnostic Testing for HER2, HER3, and TROP2 and Treatment Implications in Breast, GI, and Lung Cancers
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: July 30, 2020

Expires: July 29, 2021

Activities

Update: Testing and Treatment
Recent Developments in Testing for and Targeting HER2, HER3, and TROP2 in Patients With Advanced Breast, GI, and Other Solid Cancers
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 23, 2020

Expires: July 22, 2021

HER2/HER3/TROP2 in NSCLC
My Take on Emerging Agents Targeting HER2, HER3, and TROP2 in NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 23, 2020

Expires: November 22, 2021

T-DXd for Gastric Ca
Adding Trastuzumab Deruxtecan to the Treatment Armamentarium for Advanced Gastric Cancers
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 15, 2021

Expires: February 14, 2022

Activities

HER2 and TROP2 in MBC
MedicalMinute: Selecting Novel HER2- and TROP2-Targeted Therapeutics for Patients With Metastatic Breast Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: November 09, 2020

Expires: November 08, 2021

Coordinating Testing
MedicalMinute: Coordinating Care in the Community Setting to Improve Adherence to HER2 Testing Recommendations for MBC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2020

Expires: December 08, 2021

HER2 Testing in MBC
MedicalMinute: Expert Answers to Key Questions in HER2 Testing in Metastatic Breast Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2020

Expires: December 09, 2021

HER2/HER3 in GI
MedicalMinute: Assessment of HER2 Status and Targeting HER2 and HER3 in Gastrointestinal Cancers
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: January 08, 2021

Expires: January 07, 2022

HER2/HER3/TROP2 ADCs in Lung
MedicalMinute: Recent Advances With Antibody–Drug Conjugates Targeting HER2, HER3, and TROP2 in Lung Cancers
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: May 07, 2021

Expires: May 06, 2022

Update: HER2/HER3 in GI
MedicalMinute: Recent Advances in Targeting HER2 and HER3 in Metastatic Gastrointestinal Cancers
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: May 27, 2021

Expires: May 26, 2022

Update: HER2/HER3/TROP2 in MBC
Medical Minute: Recent Advances in HER2-, HER3-, and TROP2-Targeted Therapies for Metastatic Breast Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 07, 2021

Expires: July 06, 2022

Pharm: HER2 and TROP2 Agents
Medical Minute: Recently Approved HER2 and TROP2 Agents: Pharmacist Considerations
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 20, 2021

Expires: July 19, 2022

Faculty

cover img faculity

Mark D. Pegram, MD

Leonard M. Miller School of Medicine
University of Miami
Miami, Florida

cover img faculity

Michael F. Press, MD, PhD

Harold E. Lee Chair in Cancer Research
Professor of Pathology
Department of Pathology
University of Southern California, Norris Comprehensive Cancer Center
Los Angeles, California

cover img faculity

Kimberly Allison, MD

Professor of Pathology
Stanford University School of Medicine
Stanford, California

cover img faculity

Allison Butts, PharmD, BCOP

Clinical Pharmacy Specialist, Breast Oncology
Pharmacist Manager, Oncology
Program Director, PGY2 Hematology/Oncology Pharmacy Residency
UK Healthcare
Lexington, Kentucky

cover img faculity

Daniel Catenacci, MD

Assistant Professor of Medicine
Division of Hematology-Oncology
Department of Medicine
University of Chicago
Chicago, Illinois

cover img faculity

Axel Grothey, MD

Professor, Oncology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Yelena Y. Janjigian, MD

Associate Attending Physician
Chief, 
Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York

cover img faculity

Ian E. Krop, MD, PhD

Associate Professor of Medicine
Harvard Medical School
Associate Chief, Division of Breast Oncology
Breast Oncology Program
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Sandip P. Patel, MD

Professor, Medical Oncology, UC San Diego
Leader, Experimental Therapeutics
Deputy Director, Sanford Stem Cell Clinical Center
Co-Leader, Solid Tumor Therapeutics Program
Medical Director, Clinical Research Informatics
La Jolla, California

cover img faculity

Manish A. Shah, MD

Assistant Member, Department of Medicine, Gastrointestinal Oncology
Memorial Sloan-Kettering Cancer Center
Attending Physician, Department of Medicine, Division of Solidy Tumor Oncology
Memorial Hospital
New York, New York

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.